-
EHP-101, Possible Cannabidiol for MS, Not ‘Controlled Drug’ in Canada
EHP-101, a cannabidiol-derived therapy being developed by Emerald Health to treat multiple sclerosis, is not a “controlled substance” in Canada. Click here to find out why.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.